Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Former Roche man Guido Magni joins Versant

March 22, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm

Dr Guido Magni is joining US-based firm Versant Ventures as a venture partner to further strengthen the firm’s investment team …
Appointment
Abbott image

Abbott selects ‘AbbVie’ as new name for R&D firm

March 21, 2012 Research and Development, Sales and Marketing Abbott

Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …
News

British biotech industry gains £200m boost

March 21, 2012 Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund

The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …
News
Merck image

Merck ends development on atrial fibrillation pill

March 20, 2012 Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation

Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …
News

UCB signs £3.6m research deal with Oxford University

March 20, 2012 Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …
News
AstraZeneca image

AstraZeneca pulls depression drug, takes $50m hit

March 20, 2012 Research and Development, Sales and Marketing AstraZeneca, R&D, depression, failure, pipeline

AstraZeneca and partner Targacept will not file their depression drug TC-5214 for regulatory review. The decision comes after disappointing Phase …
News

AstraZeneca touting for business at partnering conference

March 19, 2012 Research and Development, Sales and Marketing AstraZeneca, Bio-Europe, R&D, partnering

AstraZeneca is marketing itself as a key partner for drug development deals, ahead of a European partnering conference.  The Bio-Europe …
News
Novartis HQ

Novartis signs experimental eye drug deal

March 19, 2012 Research and Development, Sales and Marketing Novartis, ThromboGenics, vitreomacular adhesion

Novartis will develop an experimental eye drug with ThromboGenics in a pact worth nearly $500 million.  The deal has been …
News
meeting image

Meetings, bloody meetings

March 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Meetings, clinical trials

I read recently that less than 2% of NHS Trust board meeting agenda items require decisions. What happens during the …
Feature

Updated set of mandatory Article 57(2) requirements for marketing authorisation holders

March 15, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV

An updated set of mandatory requirements for Marketing Authorisation Holders (MAH) to comply with Article 57(2) of the forthcoming new …
News
Press release

Photodynamic treatment for HPV shows potential

March 15, 2012 Research and Development Cancer, GE Healthcare, HPV, Photocure, ipsen, oncologly

A new photodynamic therapy treatment for human papilloma virus (HPV) associated diseases of the cervix has shown potential in a …
News

Cmed release Global Strategic and Regulatory Consulting Booklet

March 14, 2012 Research and Development

The regulatory environments within the industry continue to change and vary internationally. Cmed’s regulatory and medical professionals keep track of …
Feature
Press release
White paper

Europe’s pharma sector : living through the crisis

March 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma

Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …
Feature
Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012 Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
News
Merck image

Merck warned over missing Januvia safety study

March 13, 2012 Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026